Past, present and future of anti-IgE biologicals

由 Guntern, Pascal, Eggel, Alexander
發表在 Allergy (2020)

The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab

由 Gasser, Pascal, Tarchevskaya, Svetlana S., Guntern, Pascal, Brigger, Daniel, Ruppli, Rahel, Zbären, Noemi, Kleinboelting, Silke, Heusser, Christoph, Jardetzky, Theodore S., Eggel, Alexander
發表在 Nat Commun (2020)

Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old age

由 Brigger, Daniel, Riether, Carsten, van Brummelen, Robin, Mosher, Kira I., Shiu, Alicia, Ding, Zhaoqing, Zbären, Noemi, Gasser, Pascal, Guntern, Pascal, Yousef, Hanadie, Castellano, Joseph M., Storni, Federico, Graff-Radford, Neill, Britschgi, Markus, Grandgirard, Denis, Hinterbrandner, Magdalena, Siegrist, Mark, Moullan, Norman, Hofstetter, Willy, Leib, Stephen L., Villiger, Peter M., Auwerx, Johan, Villeda, Saul A., Wyss-Coray, Tony, Noti, Mario, Eggel, Alexander
發表在 Nat Metab (2020)